Predict your next investment

HEALTHCARE | Biotechnology
oscient.com

See what CB Insights has to offer

Founded Year

1961

Stage

PIPE | IPO

Total Raised

$13.05M

About Oscient Pharmaceuticals

Oscient Pharmaceuticals develops anti-infective therapeutics

Oscient Pharmaceuticals Headquarter Location

1000 Winter Street Suite 2200

Waltham, Massachusetts, 02451,

United States

781-398-2300

Latest Oscient Pharmaceuticals News

Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Dec 2, 2016

Advertisement Topics   Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 01:53 EST 2 Dec 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation since January 2007. Key Findings Provides intelligence on Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation and its subsidiaries since 2007. Information about key financial and legal advisors for Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation's financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Oscient Pharmaceuticals Corporation formerly known as Genome Therapeutics Corporation's growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Oscient Pharmaceuticals Patents

Oscient Pharmaceuticals has filed 14 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Transcription factors
  • Biotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/30/2011

12/9/2014

Molecular biology, Genetics, Virus families, Transcription factors, Biotechnology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/30/2011

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

12/9/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Genetics, Virus families, Transcription factors, Biotechnology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.